Circulating BDNF levels reflect the progression of AD staging as an early compensatory increase in amnestic-MCI (aMCI) and early-stage AD, followed by a decrease in the late-stage AD24,114,115. The gene discussed is BDNF; the disease is Alzheimer disease.